Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.077 | 0.2 |
mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.2 |
mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |